Isolation of a cDNA clone for human antithrombin III

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Antithrombin III (ATIII) is a key plasma protease inhibitor regulating the coagulation system.
• Inherited ATIII deficiency is linked to an increased risk of thromboembolism.
• ATIII belongs to a superfamily of protease inhibitors, including alpha 1-antitrypsin and chicken ovalbumin.

Purpose of the Study:

• To investigate the structure and expression of the human ATIII gene.
• To isolate and characterize complementary DNA (cDNA) clones of ATIII from human liver mRNA.

Main Methods:

• Isolation of ATIII cDNA clones from human liver mRNA using hybridization techniques.
• Identification of clones via synthetic oligodeoxynucleotides encoding specific ATIII amino acids.
• Analysis of genomic DNA and cloned ATIII gene to determine gene copy number and physical size.

Main Results:

• Successfully isolated ATIII cDNA clones, including a 1.4 kb clone containing the coding region and 3'-untranslated region.
• Identified a sequence polymorphism at an internal PstI restriction site among different cDNA clones.
• Determined that the ATIII gene exists once per haploid genome and spans 10-16 kilobases.
• Confirmed homology between ATIII, alpha 1-antitrypsin, and ovalbumin, supporting their classification within the protease inhibitor superfamily.

Conclusions:

• The study successfully isolated and characterized human ATIII cDNA, providing a foundation for further research into its gene structure and expression.
• Findings contribute to understanding the genetic basis of ATIII function and its role in coagulation disorders.
• Homology analysis reinforces the evolutionary relationship of ATIII within the broader protease inhibitor superfamily.